IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
This Quarter Return
+15.42%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
AUM
$324M
AUM Growth
+$324M
Cap. Flow
-$25M
Cap. Flow %
-7.72%
Top 10 Hldgs %
51.2%
Holding
69
New
3
Increased
9
Reduced
7
Closed
6
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
HCM icon
51
HUTCHMED
HCM
$2.62B
$1M 0.31%
68,000
BEAM icon
52
Beam Therapeutics
BEAM
$1.9B
$919K 0.28%
23,500
NTLA icon
53
Intellia Therapeutics
NTLA
$1.26B
$837K 0.26%
24,000
ALBO
54
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
$820K 0.25%
38,000
+21,907
+136% +$473K
INSM icon
55
Insmed
INSM
$30.3B
$800K 0.25%
40,100
IRWD icon
56
Ironwood Pharmaceuticals
IRWD
$201M
$743K 0.23%
60,000
BCRX icon
57
BioCryst Pharmaceuticals
BCRX
$1.74B
$654K 0.2%
57,000
ARVN icon
58
Arvinas
ARVN
$580M
$581K 0.18%
17,000
FATE icon
59
Fate Therapeutics
FATE
$115M
$464K 0.14%
46,000
-75,000
-62% -$756K
IOVA icon
60
Iovance Biotherapeutics
IOVA
$800M
$357K 0.11%
56,000
ALLO icon
61
Allogene Therapeutics
ALLO
$249M
$314K 0.1%
50,000
RLMD icon
62
Relmada Therapeutics
RLMD
$48.8M
$34.9K 0.01%
10,000
VTRS icon
63
Viatris
VTRS
$12.3B
-364,000
Closed -$3.1M
NBIX icon
64
Neurocrine Biosciences
NBIX
$13.5B
-30,000
Closed -$3.19M
MDGL icon
65
Madrigal Pharmaceuticals
MDGL
$9.7B
-5,350
Closed -$348K
KALV icon
66
KalVista Pharmaceuticals
KALV
$713M
-316,133
Closed -$4.59M
GLPG icon
67
Galapagos
GLPG
$2.06B
-123,300
Closed -$5.25M
AXSM icon
68
Axsome Therapeutics
AXSM
$6.09B
-14,000
Closed -$625K